FRA:ABL • US0028241000
We assign a fundamental rating of 6 out of 10 to ABL. ABL was compared to 67 industry peers in the Health Care Equipment & Supplies industry. ABL scores excellent on profitability, but there are some minor concerns on its financial health. ABL is not valued too expensively and it also shows a decent growth rate.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.6% | ||
| ROE | 27.43% | ||
| ROIC | 8.88% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.29% | ||
| PM (TTM) | 31.88% | ||
| GM | 56.19% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 1.87 | ||
| Altman-Z | 5.32 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.24 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.79 | ||
| Fwd PE | 19.52 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.18 | ||
| EV/EBITDA | 17.93 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.26% |
FRA:ABL (2/16/2026, 7:00:00 PM)
94.56
0 (0%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.26% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.79 | ||
| Fwd PE | 19.52 | ||
| P/S | 4.45 | ||
| P/FCF | 28.18 | ||
| P/OCF | 21.38 | ||
| P/B | 3.83 | ||
| P/tB | 9.12 | ||
| EV/EBITDA | 17.93 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.6% | ||
| ROE | 27.43% | ||
| ROCE | 11.52% | ||
| ROIC | 8.88% | ||
| ROICexc | 9.99% | ||
| ROICexgc | 19.14% | ||
| OM | 18.29% | ||
| PM (TTM) | 31.88% | ||
| GM | 56.19% | ||
| FCFM | 15.78% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 1.87 | ||
| Debt/EBITDA | 1.04 | ||
| Cap/Depr | 70.33% | ||
| Cap/Sales | 5.02% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 81.77% | ||
| Profit Quality | 49.49% | ||
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.24 | ||
| Altman-Z | 5.32 |
ChartMill assigns a fundamental rating of 6 / 10 to ABL.DE.
ChartMill assigns a valuation rating of 4 / 10 to ABBOTT LABORATORIES (ABL.DE). This can be considered as Fairly Valued.
ABBOTT LABORATORIES (ABL.DE) has a profitability rating of 7 / 10.
The Price/Earnings (PE) ratio for ABBOTT LABORATORIES (ABL.DE) is 21.79 and the Price/Book (PB) ratio is 3.83.
The dividend rating of ABBOTT LABORATORIES (ABL.DE) is 6 / 10 and the dividend payout ratio is 28.93%.